KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Insulet (PODD) Gains from Investment Securities (2016 - 2025)

Insulet (PODD) has disclosed Gains from Investment Securities for 16 consecutive years, with -$22.9 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Gains from Investment Securities fell 22800.0% year-over-year to -$22.9 million, compared with a TTM value of -$6.0 million through Sep 2025, down 200.0%, and an annual FY2022 reading of $15.3 million, down 45.74% over the prior year.
  • Gains from Investment Securities was -$22.9 million for Q3 2025 at Insulet, down from $1.7 million in the prior quarter.
  • Across five years, Gains from Investment Securities topped out at $27.1 million in Q3 2021 and bottomed at -$22.9 million in Q3 2025.
  • Average Gains from Investment Securities over 5 years is $2.7 million, with a median of $1.1 million recorded in 2021.
  • The sharpest move saw Gains from Investment Securities soared 27000.0% in 2021, then tumbled 22800.0% in 2025.
  • Year by year, Gains from Investment Securities stood at $600000.0 in 2021, then surged by 433.33% to $3.2 million in 2022, then tumbled by 503.12% to -$12.9 million in 2023, then surged by 53.49% to -$6.0 million in 2024, then crashed by 281.67% to -$22.9 million in 2025.
  • Business Quant data shows Gains from Investment Securities for PODD at -$22.9 million in Q3 2025, $1.7 million in Q2 2025, and $21.2 million in Q1 2025.